Novozymes: to acquire Indian enzyme business
Bagsvaerd / DK. (nz) Novozymes acquires Biocon´s enzyme business for an agreed purchase price equivalent to 551 million DKK. Novozymes thereby strengthens its position in India. Biocon is one of India´s leading biotechnology companies, specialising in biopharmaceuticals, contract research, clinical research and enzymes.